HSA — authorised 14 January 1960
- Marketing authorisation holder: LEDERLE
- Status: likely_approved
HSA authorised Demethylchlortetracycline on 14 January 1960
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 14 January 1960.
LEDERLE holds the Singaporean marketing authorisation.